The Angelman Syndrome Foundation accepts biannual research proposals in the preclinical, translational and clinical research areas that investigate all aspects of Angelman syndrome.
Applicant citizenship: United States
Host country: United States
Years since PhD: NA
Award: $200,000 max
Award Duration (years): 1-2
Research costs:
Benefits:
Mobility rule: No
Subjects: Medicine and Health Sciences
Additional comments: Priority will be given to the following topics: Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion; Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS; Projects studying delivery of therapies and potential for improvement; Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
How to apply? For further eligibility requirements and the application process, please visit: Official Funding website
This entry has been last updated: 2020-05-23 17:33:08